Velocity Time Integral vs PICCO for Evaluation of Passive Leg Raising in Septic Shock (VIPS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03621449 |
|
Recruitment Status :
Withdrawn
(Lack of funding)
First Posted : August 8, 2018
Last Update Posted : January 11, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Septic Shock |
| Study Type : | Observational |
| Actual Enrollment : | 0 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Velocity Time Integral vs PICCO for Evaluation of Passive Leg Raising in Septic Shock |
| Estimated Study Start Date : | September 1, 2021 |
| Estimated Primary Completion Date : | December 30, 2022 |
| Estimated Study Completion Date : | December 30, 2022 |
- Area under the receiver operator characteristics curve for prediction of fluid responsiveness. [ Time Frame: Cardiac output will be measured immediately prior to passive leg raising and 1 minute after completion of passive leg raising ]Prediction of fluid responsiveness by evaluation change in cardiac output using either transthoracic ultrasound or calibrated pulse contour analysis after a passive leg raising.
- Positive and negative likelihood ratios [ Time Frame: Cardiac output will be measured immediately prior to passive leg raising and 1 minute after completion of passive leg raising ]Prediction of fluid responsiveness by evaluation change in cardiac output using either transthoracic ultrasound or calibrated pulse contour analysis after a passive leg raising.
- Usefulness [ Time Frame: During screening or during examination ]Number of eligible patients in which respective method could not be used
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Septic shock according to the sepsis-3 criteria
- The treating physician plans to administer fluid to improve organ perfusion and oxygenation due to signs of inadequate organ perfusion and hypoxia (skin mottling, tachycardia (>100), urine output below 0.5 ml/kg/h, lactate persistently > 2 mmol/l and central venous oxygen saturation < 70%, increasing doses of vasoconstrictors to maintain mean arterial pressure >65 mmHg.
- Hemodynamic monitoring with transpulmonary thermodilution initiated as part of routine clinical monitoring.
Exclusion Criteria:
- Any condition that will affect the reliability of the PLR procedure or is a contraindication to PLR (compression stockings or intraabdominal pressure > 12 mm Hg, raised intracranial pressure).
- PaO2/FiO2 < 100 mmHg (13.3 kPa) or suspicion of cardiogenic edema
- Transthoracic echo does not allow recording of VTI.
- Age >18 years.
- No informed consent
- Prior inclusion in the study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03621449
| Sweden | |
| Helsingborg Hospital | |
| Helsingborg, Sweden | |
| Skåne University Hospital | |
| Malmö, Sweden | |
| Principal Investigator: | Peter Bentzer, MD, PhD | Medical faculty, Lund University |
| Responsible Party: | Region Skane |
| ClinicalTrials.gov Identifier: | NCT03621449 |
| Other Study ID Numbers: |
RegionSkane ICU 1 |
| First Posted: | August 8, 2018 Key Record Dates |
| Last Update Posted: | January 11, 2022 |
| Last Verified: | January 2022 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
passive leg raising fluid responsiveness pulse contour analysis transthoracic ultrasound velocity time integral |
|
Shock, Septic Shock Pathologic Processes Sepsis |
Infections Systemic Inflammatory Response Syndrome Inflammation |

